Tuesday, January 16, 2018

A matter of mobility: New strategy for drug discovery

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results suggest a new strategy for drug discovery.

from Top Health News -- ScienceDaily http://ift.tt/2D9ekPi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New Alzheimer's drug repairs DNA damage and reduces brain inflammation

A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 rep...